BioCentury
ARTICLE | Company News

Ilaris gets label expansion, Regeneron shares jump

May 11, 2013 12:36 AM UTC

FDA approved a regulatory application from Novartis AG (NYSE:NVS; SIX:NOVN) to expand the label for Ilaris canakinumab to include treatment of systemic juvenile idiopathic arthritis. The news sent sha...